Live News Categoriesmarket

ASXATH (ASXATH) News

Follow ASXATH (ASXATH) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ASXATH Asset market Sector Markets 90 days 0 Updated Jul 07, 2026, 02:36 AM UTC Open live news feed

L Alterity Therapeutics Says US FDA Meeting Minutes Confirm Key Elements of Phase 3 MSA Treatment Candidate Program; Shares Fall 4% () -- Alterity Therapeutics (ASX:ATH) said the official meeting minutes from its end-of phase-2 meeting for its ATH434 treatment candidate in multiple system atrophy (MSA) from the US Food and Drug Administration (FDA) c REGULATION | Jul 07, 2026, 02:36 AM UTC